Delivery Order SPE2DR25D3104-SPE2DR26FE9DS
- Not listed
- The Defense Logistics Agency awarded a $8,745.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Zepbound 5 mg/0.5 ml pens. The contract, which has no set-aside designation, is scheduled for completion by December 2, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a $22,463.06 delivery order to AmerisourceBergen Drug Corp for Zepbound 15 mg/0.5 mL pens on November 17, 2025, with an ultimate completion date of November 18, 2025. This non-set-aside contract employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical distributor,...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $16,157.68 on December 18, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pen injections. This non-competitive, firm fixed-price delivery order is set to be completed by December 19, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal...
- The Defense Logistics Agency awarded a $1,107.42 firm fixed price delivery order to AmerisourceBergen Drug Corp for Zepbound 2.5 mg/0.5 ml pen injections on December 9, 2025, with completion scheduled for December 10, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $1,607.30 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pens on December 22, 2025, with completion scheduled for December 23, 2025. This is a firm fixed price delivery order with no set-aside designation, issued under a competitive procurement process. The pharmaceutical product will be delivered to the company's place of performance in Conshohocken, Pennsylvania. This award represents a child contract...
- The Defense Logistics Agency awarded a $1,306.78 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Zepbound 5 mg/0.5 mL pens. This competitive award, with a completion date of July 30, 2025, represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply arrangements with the federal government. The order will be fulfilled from the vendor's Conshohocken, Pennsylvania location, where the company operates as a major...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $5,360.72 for Zepbound 7.5 mg/0.5 mL pens on August 1, 2025, with an ultimate completion date of August 4, 2025. This competitive, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a...
- The Defense Logistics Agency awarded a $39,361.52 delivery order to AmerisourceBergen Drug Corp on December 12, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pen injections, with performance completion targeted for December 15, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a child contract under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The place of performance is...
- The Defense Logistics Agency awarded a $65,338 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Zepbound 15 mg/0.5 mL pens. This competitively awarded contract, which carries a completion date of September 24, 2025, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child delivery order under a larger contract vehicle, this award leverages AmerisourceBergen's established relationship with...
- The Defense Logistics Agency (DLA) awarded a $16,914.66 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pens on July 14, 2025, with completion targeted for July 15, 2025. This non-set-aside contract represents a single delivery order issued under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's Conshohocken, Pennsylvania location, which...
- SPE2DR25D3104Indefinite Delivery Contract
- SPE2DR25D3104-SPE2DR26FE9DSDelivery Order
The Defense Logistics Agency awarded a $15,075.62 delivery order to AmerisourceBergen Drug Corp on December 30, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pens. The order, which serves as a child contract under AmerisourceBergen's larger indefinite delivery vehicle with DLA, is designated as a firm fixed-price delivery order with no set-aside provisions and is scheduled for completion by December 31, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's broader $999,999,999.00 Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement running through December 2026. AmerisourceBergen, a major pharmaceutical distributor and critical federal healthcare vendor, supplies a wide range of medications and medical products to support military and veteran healthcare systems. The Zepbound supply fulfills federal medical procurement requirements for diabetes management, consistent with the contractor's extensive portfolio of competitively awarded pharmaceutical deliveries to Defense Health Agency and other government healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.1k | 12/29/25 |